●Biome Australia updates its Company Presentation ●Biome Australia schedules webinar for Friday 7th March, 10.00am-10.45am AEDT ●Webinar details and registration… Read more
Financial Highlights ● Biome reports its fi rst net profi t in H1 FY25 ○ +$96,228 (excluding R&D rebate) ○… Read more
● Biome signs co-investment agreement with Australia’s Food and Beverage Accelerator (FaBA) for a jointly funded IP development program ●… Read more
● Biome has received positive results of core functional characterisation studies of its strain BMB18 ● The strain demonstrated an… Read more
● Biome increases its distribution in Australian practitioner and pharmacy markets to 6,000+ locations ● 20% growth in distribution footprint… Read more
● Biome records $234k EBITDA for Q2, up 92% vs Q11 ● Record cash receipts of $4.34m in Q2, up… Read more
Biome Australia Limited (ASX: BIO) has reported impressive financial results for the second quarter of fiscal year 2025 (Q2 FY25). Financial… Read more
● Biome forecast Q2 FY25 sales revenue to surpass $4.5m
Over 5,000 distribution points (Aus) following successful launch with Priceline Pharmacy Average shopper ~2 units per transaction and 6 visits… Read more
Sign up to our mailing list to access our research reports.
By submitting your details, you agree to our Terms of Service.